Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY-NC 4.0Investigative and Clinical Urology

Prostate cancer screening beyond opportunistic testing: A Delphi consensus and evidence integration

5 more authors
16 affiliations
  1. 1Department of Urology, Veterans Health Service Medical Center, Seoul, Korea .
  2. 2Department of Urology, Ewha Womans University Urology Institute, Ewha Womans University Mokdong Hospital, Seoul, Korea .
  3. 3Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea .
  4. 4Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea .
  5. 5Department of Urology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea .
  6. 6Department of Urology, Keimyung University Dongsan Hospital, Daegu, Korea .
  7. 7Department of Urology, Hanyang University College of Medicine, Seoul, Korea .
  8. 8Department of Urology, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea .
  9. 9Department of Urology, Urological Cancer Center, National Cancer Center, Goyang, Korea .
  10. 10Department of Urology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea .
  11. 11Department of Urology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea .
  12. 12Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea .
  13. 13Department of Urology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea .
  14. 14Department of Urology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea .
  15. 15Division of Health Administration, College of Health Science, Yonsei University, Wonju, Korea .
  16. 16Institute for Planetary Health, Yonsei University, Wonju, Korea .

Abstract

Purpose: Prostate cancer has become the most common male malignancy in Korea, yet prostate-specific antigen (PSA)–based screening remains excluded from the national cancer screening program and is performed predominantly on an opportunistic basis. Long-term randomized evidence comparing organized PSA-based screening with opportunistic testing is complex and variably interpreted. This study aimed to assess expert consensus on whether an organized early-detection framework offers advantages over the current opportunistic model in Korea.

Materials and Methods: A structured, three-round Delphi study was conducted among 15 Korean urologists with expertise in prostate cancer management and PSA-based early detection. Statements were informed by international guidelines, long-term randomized trial evidence, and Korean epidemiologic data, covering conceptual justification and screening parameters. Consensus was predefined using Likert-scale agreement/disagreement thresholds and a within-group agreement index (rwg ≥0.80).

Results: All panelists completed all three rounds. Consensus was achieved that PSA-based early detection provides a net population-level benefit; that organized, invitation-based screening is preferable to opportunistic testing; and that active surveillance should be the default for low-risk disease. Initiation at age 55 reached stable consensus, whereas discontinuation at age 80 reached consensus only in the final round, indicating an upper bound within an individualized 75- to 80-year stopping range. No fixed screening interval achieved sustained agreement, supporting risk-adapted approaches.

Conclusions: This Delphi study supports the feasibility of an organized, risk-adapted PSA-based early detection framework in Korea. Subsequent multidisciplinary input from preventive medicine, primary care, health economics, and patient perspectives is required before policy implementation.

Related

  1. Biomarker use in the prostate cancer screening pathway: Maps of the evidence
    Rita L. Shiau, Jessica C. Griffin, Clarissa A. B. Troutman +2
    CancerPeer-reviewedCC BY-NC-ND 4.0Full text2 citedGeneral medicinePMC
  2. Federated learning for privacy-preserving opportunistic screening of lumbar-spine DXA-defined osteoporotic-level bone mineral density using chest radiographs: A multi-center independent validation study
    Bo-Ru Lin, Ming-Yueh Huang, Wei-Chung Sun +4
    Osteoporosis and sarcopeniaPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Histopathological Spectrum and Yield of Advanced Neoplasia in Opportunistic Colonoscopy Without Organised Screening: A Single-Centre Cross-Sectional Study from Western Romania
    Alina Anton, Dan Brebu, Meda-Ada Bugi +13
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. CT-Defined Osteosarcopenia Is Associated with Mortality in Metastatic Prostate Cancer: A Longitudinal Analysis of Opportunistic CT Imaging
    Tayler D. Ross, Saleh Tabatabaei, Rose Yakubov +3
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  5. Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models.
    Tony S K Mok, Christian Finley, Deniz Köksal +4
    Lung cancer managementPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
BibTeX
@article{ryu2026prostate,
  title = {{Prostate cancer screening beyond opportunistic testing: A Delphi consensus and evidence integration}},
  author = {Jae Hyun Ryu and Young Hwii Ko and Jungyo Suh and Hyunho Han and Woojin Bang and Byung Hoon Kim and Sung Yul Park and Jae-Seung Chung and Jae Young Joung and Seok-Soo Byun and Sung-Woo Park and Byong Chang Jeong and Kwan Joong Joo and Young Goo Lee and Min-Hee Heo and Jin-Won Noh and Seong Il Seo},
  journal = {Investigative and Clinical Urology},
  year = {2026},
  month = oct,
  doi = {10.4111/icu.20260128},
  url = {https://doi.org/10.4111/icu.20260128},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Prostate cancer screening beyond opportunistic testing: A Delphi consensus and evidence integration
AU  - Jae Hyun Ryu
AU  - Young Hwii Ko
AU  - Jungyo Suh
AU  - Hyunho Han
AU  - Woojin Bang
AU  - Byung Hoon Kim
AU  - Sung Yul Park
AU  - Jae-Seung Chung
AU  - Jae Young Joung
AU  - Seok-Soo Byun
AU  - Sung-Woo Park
AU  - Byong Chang Jeong
AU  - Kwan Joong Joo
AU  - Young Goo Lee
AU  - Min-Hee Heo
AU  - Jin-Won Noh
AU  - Seong Il Seo
PY  - 2026
DA  - 2026/10/21
JO  - Investigative and Clinical Urology
DO  - 10.4111/icu.20260128
UR  - https://doi.org/10.4111/icu.20260128
AB  - Purpose: Prostate cancer has become the most common male malignancy in Korea, yet prostate-specific antigen (PSA)–based screening remains excluded from the national cancer screening program and is performed predominantly on an opportunistic basis. Long-term randomized evidence comparing organized PSA-based screening with opportunistic testing is complex and variably interpreted. This study aimed to assess expert consensus on whether an organized early-detection framework offers advantages over the current opportunistic model in Korea.  Materials and Methods: A structured, three-round Delphi study was conducted among 15 Korean urologists with expertise in prostate cancer management and PSA-based early detection. Statements were informed by international guidelines, long-term randomized trial evidence, and Korean epidemiologic data, covering conceptual justification and screening parameters. Consensus was predefined using Likert-scale agreement/disagreement thresholds and a within-group agreement index (rwg ≥0.80).  Results: All panelists completed all three rounds. Consensus was achieved that PSA-based early detection provides a net population-level benefit; that organized, invitation-based screening is preferable to opportunistic testing; and that active surveillance should be the default for low-risk disease. Initiation at age 55 reached stable consensus, whereas discontinuation at age 80 reached consensus only in the final round, indicating an upper bound within an individualized 75- to 80-year stopping range. No fixed screening interval achieved sustained agreement, supporting risk-adapted approaches.  Conclusions: This Delphi study supports the feasibility of an organized, risk-adapted PSA-based early detection framework in Korea. Subsequent multidisciplinary input from preventive medicine, primary care, health economics, and patient perspectives is required before policy implementation.
SN  - 2466-0493
SN  - 2466-054X
ER  -